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The ability of Mycobacterium tuberculosis to grow in macrophages is critical to the virulence of this important pathogen. One
way M. tuberculosis is thought to maintain a hospitable niche in macrophages is by arresting the normal process of phagosomes
maturing into acidified phagolysosomes. The process of phagosome maturation arrest by M. tuberculosis is not fully under-
stood, and there has remained a need to firmly establish a requirement for phagosome maturation arrest for M. tuberculosis
growth in macrophages. Other intracellular pathogens that control the phagosomal environment use specialized protein export
systems to deliver effectors of phagosome trafficking to the host cell. In M. tuberculosis, the accessory SecA2 system is a special-
ized protein export system that is required for intracellular growth in macrophages. In studying the importance of the SecA2
system in macrophages, we discovered that SecA2 is required for phagosome maturation arrest. Shortly after infection, phago-
somes containing a secA2 mutant of M. tuberculosis were more acidified and showed greater association with markers of late
endosomes than phagosomes containing wild-type M. tuberculosis. We further showed that inhibitors of phagosome acidifica-
tion rescued the intracellular growth defect of the secA2 mutant, which demonstrated that the phagosome maturation arrest
defect of the secA2 mutant is responsible for the intracellular growth defect. This study demonstrates the importance of phago-
some maturation arrest for M. tuberculosis growth in macrophages, and it suggests there are effectors of phagosome maturation
that are exported into the host environment by the accessory SecA2 system.
Mycobacterium tuberculosis infects about one-third of theworld population and, as the infectious agent of tuberculo-
sis, causes almost 2 million deaths per year (69). With the emer-
gence of drug-resistant strains of M. tuberculosis, current treat-
ments may soon become obsolete, fueling the need for new drugs
and more effective vaccines to combat the disease. A better under-
standing of M. tuberculosis pathogenesis will facilitate efforts to
develop new tuberculosis control measures.
Inside the host, M. tuberculosis survives in a unique intracellu-
lar niche within macrophage phagosomes. Following its phagocy-
tosis by nonactivated macrophages, M. tuberculosis arrests the
normal process of phagosome maturation. As a result, M. tuber-
culosis resides in a phagosome that fails to acidify or fuse with
late endosomes and lysosomes that supply hydrolytic enzymes
and antimicrobial peptides (2, 52). This M. tuberculosis phago-
some resembles an early recycling endosome that is accessible
to transferrin and maintains a pH of 6.4 (46). M. tuberculosis-
containing phagosomes are further distinguished by dimin-
ished accumulation of vacuolar ATPase (V-ATPase),
phosphatidylinositol-3-phosphate [PI(3)P], and activated
Rab7, which normally accumulate on maturing phagosomes
(54, 57, 62, 63, 65). While the ability of M. tuberculosis to block
phagosome maturation is widely thought to play an important
role in promoting M. tuberculosis intracellular growth, there
are few experiments that directly address a causal relationship
between phagosome maturation arrest and intracellular
growth. Furthermore, the mechanism M. tuberculosis uses to
prevent phagosomes from maturing into acidic hydrolytic
compartments is not well understood but appears to be a mul-
tifactorial process involving both protein and lipid effectors (3,
8, 14, 21, 36, 46, 56, 59, 63, 67).
M. tuberculosis effectors that alter phagosome trafficking are
likely molecules that are exported by the bacillus (either secreted
or surface localized) and positioned to interact with host cell pro-
cesses. With the intracellular pathogens Legionella and Salmonella,
specialized secretion systems are used to deliver effectors of
phagosome trafficking (9, 13). M. tuberculosis has two types of
specialized protein export system: the ESX systems and the acces-
sory SecA2 system (16). The ESX-1 secretion system has previ-
ously been shown to block phagosome maturation in M.
tuberculosis-infected macrophages (8, 36). Here, we investigated
the accessory SecA2 protein export system of M. tuberculosis and
its role in virulence and phagosome maturation arrest. Mycobac-
teria are unusual in having two distinct SecA ATPase proteins
(SecA1 and SecA2) (27, 51). SecA2 is an accessory SecA that is
required for exporting a small subset of proteins out of the cyto-
plasm. SecA1, as the housekeeping SecA, is essential and functions
in the general Sec pathway that is used for the majority of protein
export that occurs in mycobacteria.
The M. tuberculosis SecA2 system is important for virulence (6,
33). A secA2 mutant of M. tuberculosis is attenuated for growth in
macrophages and in a mouse model of infection. A possible expla-
nation for the function of the M. tuberculosis SecA2 system in
pathogenesis might be to modulate host innate immune re-
sponses. Macrophages infected with the secA2 mutant produce
higher levels of the proinflammatory cytokines tumor necrosis
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factor alpha (TNF-) and interleukin 6 (IL-6) and increased levels
of reactive nitrogen intermediates (RNI). These immunomodula-
tory factors have roles in controlling M. tuberculosis during host
infection (19, 34, 38), and they are induced by M. tuberculosis
through MyD88-dependent signaling pathways (reviewed in ref-
erence 29). Macrophages infected with the secA2 mutant also
exhibit higher levels of apoptosis, which is attributed to defective
SodA secretion by the secA2 mutant (25).
Here, we studied the secA2 mutant to take a closer look at the
role of SecA2 during M. tuberculosis growth in macrophages. We
examined the roles of apoptosis and increased MyD88-dependent
inflammatory responses in controlling growth of the secA2 mu-
tant in macrophages. While these macrophage responses did not
appear to explain the role of SecA2 in promoting intracellular
growth, we did discover an important role for SecA2 in blocking
phagosome maturation. We go on to show that SecA2-dependent
phagosome maturation arrest is required for the growth of M.
tuberculosis in macrophages.
MATERIALS AND METHODS
Bacterial strains and growth conditions. In this study, we used the M.
tuberculosis strains listed in Table 1. M. tuberculosis strains were cultured
in liquid Middlebrook 7H9 medium or solid 7H10 supplemented with
0.05% Tween 80, 0.5% glycerol, 1 albumin dextrose saline (ADS), and
appropriate drugs (kanamycin [20 g/ml] or hygromycin [50 g/ml]).
For plating organ homogenates from murine infections, cycloheximide
(10 g/ml) was incorporated into 7H10 agar to inhibit fungal growth. For
experiments with the leuD mutant, all media were additionally supple-
mented with 50 g/ml L-leucine.
Mutant construction. The M. tuberculosis eccD1-null mutant was
constructed by specialized transduction using an allelic-exchange con-
struct delivered by the temperature-sensitive mycobacteriophage
phAE159, as described previously (5). The allelic-exchange construct was
constructed by amplifying flanking regions of eccD1 (rv3877) by PCR
from M. tuberculosis genomic DNA. An 833-bp upstream flanking se-
quence (ending at the second codon of eccD1) and an 821-bp downstream
flanking sequence (starting at the fifth codon from the stop) were ampli-
fied and individually cloned into the pCR 2.1 cloning vector (Invitrogen).
These flanking sequences were then sequentially cloned into pJSC284 to
create plasmid pKO-3877, which has the hygromycin (hyg) cassette mark-
ing the deletion and positioned between the two flanking sequences. PacI-
digested pKO-3877 was then ligated to PacI-cut phAE159 and in vitro
packaged (Stratagene) into lambda phage particles that were recovered by
transduction in Escherichia coli. The resulting recombinant mycobacte-
riophage was then used to transduce H37Rv at the nonpermissive tem-
perature of 39°C for 4 h. The transduced cells were pelleted, resuspended
in 7H9 medium with 0.1% Tween 80, and plated on 7H10 agar with
hygromycin. Hygromycin-resistant colonies obtained at 3 weeks were
screened for allelic exchange by Southern blotting to confirm deletion of
eccD1.
The secA2-null mutant in Mycobacterium bovis BCG Pasteur was
constructed as previously reported for BCG Tice and H37Rv strains using
a two-step allelic-exchange method (6, 53).
Antibodies and reagents. Antibodies to mammalian markers (CD63,
Rab7, and V-ATPase B1/B2) and fluorophore-conjugated secondary an-
tibodies were acquired from Santa Cruz Biotechnology. The -SodA con-
struct (pMV3-sod) was a kind gift from William Jacobs, Jr. (Albert Ein-
stein College of Medicine, Bronx, NY) (25). Bafilomycin A1 (Sigma) and
concanamycin A (Santa Cruz) were stocked at 1,000 in dimethyl sulfox-
ide (DMSO).
Animals. C57BL/6 mice acquired from Charles River Laboratories
were used in aerosol infections and for bone marrow-derived macro-
phages (BMDM). MyD88/ mice on the C57BL/6 background (1) were
acquired from Shizuo Akira (WPI Immunology Frontier Research Cen-
ter, Research Institute for Microbial Diseases, Osaka University, Osaka,
Japan). All mice were housed in sterile cages and provided sterile food and
water. All animal protocols were followed strictly as approved by the UNC
Institutional Animal Care and Use Committee (IACUC).
Aerosol infection and necropsy. Aerosol infection of mice was per-
formed using a Madison aerosol chamber. Briefly, mice were exposed to a
whole-body aerosol generated from M. tuberculosis that was grown to log
phase, washed once, and resuspended in phosphate-buffered saline (PBS)
containing 0.05% Tween 80 at a concentration of 1.2  107 CFU/ml. The
mice were exposed to aerosols for 15 min with a 20-min purge to clear the
chamber, resulting in an approximate dose of 200 CFU/lung. At various
time points, the mice were euthanized, and their lungs and spleens were
homogenized and plated for CFU on 7H10 agar.
Macrophage infections. Bone marrow-derived macrophages were
made as follows. Mice were euthanized by CO2 asphyxiation and cervical
dislocation. The femurs were removed, and bone marrow was flushed out
with supplemented Dulbecco modified Eagle medium (DMEM) (Sigma).
The DMEM was supplemented with 10% fetal bovine serum (FBS)
(Gibco), 2 mM L-glutamine, and 1 nonessential amino acids (complete
DMEM). The bone marrow cells were washed once, resuspended, and
plated in complete DMEM containing 20% L-929 cell-conditioned me-
dium (LCM). After 6 days at 37°C, 5% CO2, the cells were lifted off the
plates using cold PBS-5 mM EDTA and scraping. The cells were then
washed twice and resuspended at a concentration of 1  106 macro-
phages/ml in complete DMEM containing 10% LCM. The macrophages
were then seeded at 2  105/well in eight-well chambered slides or cham-
bered coverslips for microscopy experiments.
After resting 24 to 48 h, the macrophages were infected with M. tuber-
culosis culture grown to log phase, washed once with PBS containing
0.05% Tween 80, and diluted in warm complete DMEM. The macro-
phages were infected at a multiplicity of infection (MOI) of 1.0 for mi-
croscopy or 0.2 for intracellular-growth assays. After a 4-h incubation at
37°C for bacterial uptake, the infected macrophages were washed three
times with prewarmed complete DMEM. The zero-hour time point of
these experiments represents the time after the washes were complete. For
kinetic growth assays, the macrophages were lysed at various time points,
and the lysates were plated for CFU. For microscopy, coverslips were
taken at various time points and fixed for at least 1 h in 4% paraformal-
dehyde (PFA) in PBS, pH 7.4. For experiments using bafilomycin A1
(Sigma) or concanamycin A (Santa Cruz), the inhibitors or equivalent
TABLE 1 Mycobacterium strains used
Strain Description Reference or source
M. tuberculosis
H37Rv Wild type Trudeau Institute
mc23112 H37Rv secA2 6
MBTB74 H37Rv secA2 attB::secA2 This study
MBTB109 H37Rv secA2 attB::sodA 25, this study
mc23032 H37Rv leuD 26
MBTB3 H37Rv eccD1 This study
PM638 H37Rv blaC 18
MBTB204 PM638; mce1A::tn 40
MBTB156 PM638; mce2F::tn 40
MBTB183 PM638; rv0199::tn 40
MBTB157 H37Rv; gfp This study
MBTB158 mc23112; gfp This study
MBTB159 MBTB74; gfp This study
MBTB390 mc23032; gfp This study
M. bovis BCG
BCG Pasteur Wild type Staten Serum Institut
MB544 BCG Pasteur secA2 This study
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vehicle control was added to the macrophages 30 min prior to infection.
The inhibitors were maintained throughout the 5-day infection.
Macrophage staining and microscopy. To stain with LysoTracker,
medium was replaced with prewarmed DMEM plus 100 nM LysoTracker
Red DND99 (Invitrogen) and returned to 37°C, 5% CO2 for 1 h. For
immunofluorescence, the medium was aspirated from the wells at the
endpoint of infection, and the coverslips were submerged in 4% PFA for at
least 1 h. To stain for immunofluorescence, fixed macrophages in cham-
bered coverslips were submerged in PBS to remove residual PFA. The cells
were then permeabilized with 0.1% Triton X-100 in PBS for 5 min at room
temperature, washed in PBS, and blocked in PBS plus 10% serum from
the same source as the secondary antibody. Primary antibodies were used
at a 1:100 dilution in PBS plus 3% serum and incubated overnight at 4°C.
After extensive washing in PBS, secondary antibodies conjugated to fluo-
rophores were used at 1:100 in PBS plus 3% serum and incubated at room
temperature for 1 h. After secondary antibodies were washed away,
Fluormount-G (Southern Biotech) was added to each well. As an impor-
tant control, we showed that normal rabbit IgG and secondary antibody
alone did not stain M. tuberculosis-containing phagosomes.
Wide-field fluorescence microscopy was performed using an Olympus
IX-81 controlled by the Volocity software package. All images were taken
using a 40 oil immersion objective. A minimum of five fields per well
were captured, and bacteria were scored for phagosomal markers,
amounting to a minimum of 100 bacterium-containing phagosomes
scored per well. For each experimental group, three replicate wells were
scored per experiment.
Mycobacterial autofluorescence was visualized using a cyan fluores-
cent protein (CFP) filter cube (Semroc) with an excitation band of 426 to
450 nm and an emission band of 467 to 600 nm. A 3% transmission
neutral-density filter was used, and minimal time was spent focusing in
the CFP channel to protect the autofluorescence from photobleaching.
RESULTS
Increased apoptosis does not account for the intracellular-
growth defect of the M. tuberculosis secA2 mutant. The ability
of M. tuberculosis to inhibit host cell apoptosis could be important
for intracellular growth of the bacillus (41, 44). The secA2 mu-
tant has a proapoptotic phenotype, which has been attributed to
defective SodA secretion (25). Given this phenotype of the secA2
mutant, we set out to test if increased apoptosis accounts for the
growth defect of the mutant in macrophages. To test this possibil-
ity, we took advantage of a plasmid expressing an extra copy of
SodA, termed -SodA. Unlike the endogenous M. tuberculosis
SodA, which lacks an obvious signal sequence for export, -SodA
has a Sec signal sequence fused to the N terminus of the enzyme
(25). When -SodA is expressed by the secA2 mutant (secA2-
-sodA) it restores the ability of the secA2 mutant to release SodA
activity into the culture medium and it reverses the proapoptotic
phenotype of the mutant (25). It is worthwhile to mention that the
details of -SodA release, particularly whether it is secreted by the
Sec pathway, remain to be worked out. Nonetheless, because
-SodA suppresses the propapoptotic phenotype of the secA2
mutant, we could test the secA2--sodA strain for growth in
murine bone marrow-derived macrophages as a way to determine
if altered apoptosis is responsible for the intracellular growth phe-
notype of the secA2 mutant. In these experiments, both the
secA2 mutant and the secA2–-sodA strain failed to grow in
macrophages while the parental H37Rv strain and the comple-
mented secA2 mutant strain grew approximately 10-fold over 5
days (Fig. 1A). These results demonstrated that the secA2 mutant
remains defective for intracellular growth even if the enhanced-
apoptosis phenotype is suppressed.
We similarly tested the role of apoptosis in the attenuated phe-
notype of the secA2 mutant in mice. C57BL/6 mice were infected
via the aerosol route with the secA2–-sodA strain, and the in
vivo growth and persistence of the strain were compared to that
seen with murine infection with the secA2 mutant and H37Rv.
Here, too, the attenuated phenotype of the secA2 mutant was not
suppressed by -SodA expression. In fact, in mice, -SodA ex-
pression by the secA2 mutant actually exacerbated the in vivo
growth defect (Fig. 1B). Taken together, these results indicated
that increased apoptosis and the defect in SodA secretion are, at
least on their own, unable to explain the attenuated phenotypes of
the secA2 mutant in macrophages or mice. Thus, there must be
another role for the SecA2 system in M. tuberculosis virulence.
The secA2 mutant resides in acidified phagosomes. The
ability of M. tuberculosis to interfere with phagosome maturation
is another property of the bacillus proposed to be important for
intracellular growth (47, 52, 66). Because secreted and surface-
localized proteins of M. tuberculosis are good candidates for being
involved in phagosome maturation arrest, we tested the potential
for the SecA2 export system to influence phagosome maturation.
Murine bone marrow-derived macrophages were infected with
H37Rv, the secA2 mutant, or a complemented strain, and we
scored the bacilli for colocalization with markers of phagosome
maturation using wide-field fluorescence microscopy.
To detect bacilli in macrophages, we took advantage of the
recently described autofluorescence of mycobacteria (45). Us-
ing scanning spectrophotometry, we first experimentally deter-
FIG 1 Reversal of the secA2 mutant apoptosis phenotype does not rescue
growth in macrophages or mice. (A) Nonactivated BMDM were infected with
the H37Rv, secA2, secA2 plus psecA2 (complemented strain), or secA2 plus
-sodA strain of M. tuberculosis, and intracellular replication was monitored as
described in the text. The data shown are plotted on a linear scale and are
representative of two experiments; the points represent means of triplicate
wells, and the error bars represent standard deviations (SD). *, P  0.05 by
Student’s t test. (B) Lung and spleen burdens in mice infected through the
aerosol route at an initial dose of 200 CFU/lung with H37Rv or the secA2 or
secA2-plus--sodA strain. We determined CFU counts by plating lung or
spleen homogenates at various time points for viable bacteria. The data shown
are from a single experiment; the bars represent the mean organ burdens from
four mice, and the error bars represent SD. *, P  0.05 by Student’s t test. d,
day(s); p.i., postinfection.
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mined the optimal peak excitation and emission wavelengths
(415 nm and 470 nm, respectively) for autofluorescence of
paraformaldehyde-fixed M. tuberculosis. These wavelengths
can be detected by fluorescence microscopy using a standard
CFP filter set. To validate the use of autofluorescence to localize
M. tuberculosis, we evaluated a series of green fluorescent pro-
tein (GFP)-expressing wild-type (WT) and mutant M. tubercu-
losis strains and compared GFP and autofluorescence signals.
GFP expression is commonly used to visualize M. tuberculosis
in macrophages (65, 70). All GFP-positive cells were visible by
autofluorescence (Fig. 2); this was also true with bacilli in mac-
rophages (data not shown).
It is well established that in nonactivated macrophages, wild-
type M. tuberculosis is primarily found in nonacidified phago-
somes (46, 52, 54, 66). To assess the acidification of phagosomes
containing the secA2 mutant, we used LysoTracker Red (Invit-
rogen), which is an acidotropic dye frequently employed in stud-
ies of phagosome maturation (66, 70). By measuring the colocal-
ization of LysoTracker and M. tuberculosis autofluorescence
signals, the parental H37Rv strain was found to largely avoid
phagosome acidification, as reported previously (46, 54). In com-
parison, we detected the secA2 mutant in a significantly higher
percentage of acidified phagosomes, and this phenotype was re-
versed in the complemented strain (Fig. 3A). Experiments with
GFP-expressing versions of these strains, where GFP was used to
localize the bacilli, gave the same results as obtained by scoring
autofluorescence (data not shown). The secA2 mutant’s associ-
ation with acidified phagosomes was evident as early as 1 h postin-
fection (Fig. 3A).
We compared the phagosome acidification phenotype of the
secA2 mutant to that of a mutant defective for ESX-1 secretion
(eccD1). As reported previously for esx-1 mutants, the eccD1
mutant exhibited greater association with LysoTracker-positive
phagosomes than H37Rv (Fig. 3B) (8). The esx-1 mutant pheno-
type was repeatedly less dramatic than the secA2 mutant pheno-
type. This finding that both a secA2 mutant and esx-1 mutants
are associated with increased phagosome acidification joins a list
of other similarities reported for these mutants (20, 24, 28, 33, 37,
55). This raised the possibility that the SecA2 and ESX-1 systems
might work together to export critical effector proteins of phago-
some maturation. To test this possibility, we assayed the phago-
some acidification of an M. bovis BCG secA2 mutant. BCG lacks
ESX-1 because the chromosomal locus encoding the system is
deleted (49). As was the case in M. tuberculosis, a BCG secA2
mutant exhibited greater association with LysoTracker-
positive phagosomes than the parental BCG Pasteur strain (Fig.
3C). This result indicated that the role(s) of the SecA2 system in
arresting phagosome maturation is independent of the ESX-1
system.
FIG 2 M. tuberculosis autofluorescence can be used to identify bacilli by mi-
croscopy. The M. tuberculosis strains used in this study carrying a GFP expres-
sion plasmid were grown to mid-log phase and fixed in 4% paraformaldehyde
in PBS. The fixed bacteria were loaded into the well of a chambered coverslip
and visualized in the CFP and GFP channels on a wide-field fluorescence
microscope. Autofluorescence in the CFP channel is compared to GFP fluo-
rescence in strains expressing GFP from a plasmid. The overlap is demon-
strated in the merged images, where yellow indicates a positive correlation.
FIG 3 Compared to H37Rv, the secA2 mutant is enriched in LysoTracker-
positive phagosomes. Nonactivated BMDM were infected with H37Rv, the
secA2, mutant or the complemented strain (A); H37Rv, secA2, or eccD1
(B); or BCG Pasteur or a secA2 mutant on the BCG Pasteur background (C).
At the indicated times, the slides were stained with LysoTracker and scored for
LysoTracker-positive phagosomes, as described in the text. Also shown in
panel A are representative images from at least three independent experiments
(LT, LysoTracker). The bars represent mean percentages of bacterium-
containing phagosomes that stain positive for LysoTracker; The error bars
represent SD of three replicate wells, with each well having 100 phagosomes
scored. *, P  0.05 by Student’s t test compared to the WT.
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The localization of the secA2 mutant to acidified phago-
somes is not a general property of M. tuberculosis mutants with
intracellular-growth defects. Increased association of the secA2
mutant with acidified phagosomes could result from an inability
to carry out a role in blocking phagosome acidification, such as
failure to secrete an inhibitor of phagosome maturation. Alterna-
tively, the secA2 mutant could be delivered to acidified phago-
somes as a secondary consequence of failure to grow in macro-
phages. In considering the second possibility, we asked whether
unrelated mutants that fail to replicate in macrophages are also
found in acidified phagosomes. For this reason, we investigated
the acidification status of phagosomes containing the M. tubercu-
losis leucine auxotroph (leuD). The leuD mutant is a metabolic
mutant that fails to synthesize leucine and fails to grow in macro-
phages (26). Unlike the secA2 mutant, the leuD mutant resem-
bled H37Rv in its association with nonacidified phagosomes, even
72 h postinfection, indicating that the mutant maintained the
ability to block phagosome acidification (Fig. 4A). We addition-
ally screened for phagosome acidification defects of M. tuberculo-
sis transposon mutants recently identified as being defective for
intracellular growth (40). Transposon mutants in rv0199, mce1A,
or mce2F also resembled H37Rv in the ability to block phagosome
acidification (Fig. 4B). These data indicated that localization to
acidified phagosomes, as assessed by LysoTracker staining, is not
the case for all M. tuberculosis mutants that are defective for intra-
cellular growth. Along with the finding that the secA2 mutant is
observed in acidified phagosomes quickly (1 h) postinfection (Fig.
3, 4A), these results argue for a specific role for the SecA2 system in
blocking phagosome acidification.
Other markers of maturation are associated with phago-
somes containing the secA2 mutant. V-ATPase is a molecular
motor that drives a proton gradient across membranes.
V-ATPases are used by eukaryotic cells to acidify vacuoles. It has
been reported that M. tuberculosis phagosomes do not acidify, at
least in part, because V-ATPase is either prevented from associat-
ing with or quickly degraded from the phagosome (54, 57). We
wanted to determine if the greater association of the secA2 mu-
tant with acidified phagosomes correlates with greater V-ATPase
association. Macrophages infected with the secA2 mutant,
H37Rv, or the complemented strain were immunostained with
antibodies to murine V-ATPase, and colocalization was scored.
We found that a significantly higher percentage of phagosomes
containing the secA2 mutant stained positive for V-ATPase than
phagosomes containing H37Rv or the complemented strain (Fig.
5A). The increased association with V-ATPase-positive phago-
somes seen with the secA2 mutant was equivalent to that seen
with the eccD1 mutant.
Phagosome acidification is a relatively early step in phagosome
maturation (17). To further characterize the secA2 mutant-
containing phagosome for evidence of phagosome/lysosome fu-
sion, we immunostained infected macrophages for markers of
late-endosomal/lysosomal fusion (CD63 and Rab7). Wild-type
M. tuberculosis is reported to prevent phagosomes from maturing
to a CD63- and Rab7-positive state (12, 31, 65). In comparison to
phagosomes containing H37Rv or the complemented strain, a
higher percentage of secA2 mutant-containing phagosomes
stained positive for CD63 and Rab7. Once again, the phenotype of
the secA2 mutant was similar to that of the eccD1 mutant (Fig.
5B and C). Together, these results indicated that phagosomes con-
taining the secA2 mutant have a greater association with
V-ATPase, which could account for the observed higher percent
acidification detected with LysoTracker. The secA2 mutant-
containing phagosomes also have a greater association with mark-
ers indicative of late endosomal/lysosomal fusion, indicating a
defect in later stages of phagosome maturation arrest, as well (Fig.
5B and C).
MyD88 signaling is not responsible for the altered phago-
some maturation or intracellular-growth phenotype of the
secA2 mutant. We previously reported that during macrophage
infection, the secA2 mutant induces higher levels of TNF-, IL-6,
and RNI than infection with H37Rv (33). All three of these immu-
nomodulatory molecules are induced by M. tuberculosis through
TLR and MyD88 pathways (7, 32, 50). Because Toll-like receptor
and MyD88 signaling are implicated in driving phagosome mat-
uration events (4, 71), we considered the possibility that increased
signaling through these pathways was responsible for the traffick-
ing defects of the secA2 mutant. To address the significance of
MyD88-dependent responses to secA2 mutant phenotypes in
macrophages, we tested the secA2 mutant and H37Rv in parallel
infections of primary MyD88-deficient macrophages (MyD88/)
and C57BL/6 macrophages. As reported by others, MyD88/
macrophages showed a significant decrease in levels of secreted
TNF- and IL-6 in response to M. tuberculosis infection (22, 60).
The TNF- and IL-6 levels from H37Rv or secA2 mutant-
FIG 4 Not all M. tuberculosis mutants with intracellular growth defects are
enriched in LysoTracker-positive phagosomes. Nonactivated BMDM were in-
fected with the H37Rv, secA2, or leuD (A) or H37Rv, secA2, mce1A::tn,
mce2F::tn, or rv0199::tn (B) strain. At the indicated times, the slides were
stained with LysoTracker and scored for LysoTracker-positive phagosomes as
described in the text. Shown are representative data from at least three inde-
pendent experiments. The bars represent mean percentages of bacterium-
containing phagosomes that stain positive for LysoTracker; the error bars rep-
resent SD of three replicate wells. *, P  0.05 by Student’s t test compared to
H37Rv.
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infected MyD88/ macrophages were the same and equivalent to
the levels produced by uninfected macrophages (data not shown).
As in C57BL/6 macrophages, secA2 mutant-containing
phagosomes in MyD88/ macrophages stained positive more
than H37Rv-containing phagosomes with LysoTracker,
V-ATPase, CD63, and Rab7. The difference between the secA2
mutant and H37Rv phagosomes in MyD88/ macrophages was
equivalent to that seen in C57BL/6 macrophages (Fig. 6A). We
also tested the secA2 mutant for growth in MyD88/ macro-
phages. In MyD88/ macrophages, the secA2 mutant was as
defective for intracellular growth as is seen in C57BL/6 macro-
phages (Fig. 6B). Aerosol infection of MyD88/ mice with the
secA2 mutant also showed that the absence of MyD88/ had no
effect on the in vivo growth defect of the secA2 mutant in mice at
early time points (data not shown). Thus, the explanation for the
intracellular-trafficking and growth defects of the secA2 mutant
appears to be unrelated to MyD88 signaling.
Phagosome acidification is necessary for the intracellular-
growth phenotype of the secA2 mutant. There are other M.
tuberculosis mutants reported to have defects in blocking phago-
some maturation (8, 31, 36, 46, 56, 67). In the majority of cases,
phagosome maturation arrest mutants are also defective for intra-
cellular growth (for example, esx-1 mutants). However, with the
exception of a few studies (23, 30, 68), the causal relationship
between localization to a more mature phagosome and inhibition
of growth remains largely untested. With the goal of determining
if the phagosome maturation arrest defect of the secA2 mutant is
responsible for the growth defect in macrophages, we used mac-
rolide antibiotic V-ATPase inhibitors (bafilomycin A1 and conca-
namycin A) (15) to block acidification of secA2 mutant-
containing phagosomes and asked if this treatment rescued
growth of the mutant. To minimize pleiotropic effects of the in-
hibitors on macrophages, we experimentally determined the min-
imum concentration of each inhibitor (10 nM bafilomycin A1 and
5 nM concanamycin A) required to prevent acidification of the
secA2 mutant-containing phagosomes, as measured by Lyso-
Tracker colocalization at 24 h postinfection (Fig. 7A). These con-
centrations had no detectable effect on macrophage viability over
FIG 5 Compared to H37Rv, the secA2 mutant is enriched in phagosomes positive for late endocytic/lysosomal markers. Nonactivated BMDM were infected
with H37Rv or the secA2, complemented secA2, or eccD1 mutant for 24 h and immunofluorescently stained for markers of phagosome maturation as
described in the text. (A) V-ATPase. (B) CD63. (C) Rab7. A representative of three independent experiments is shown. The bars represent mean percentages of
bacterium-containing phagosomes that stain positive for marker; the error bars represent SD of three replicate wells, with each well having 100 phagosomes
scored. *, P  0.05 by Student’s t test compared to H37Rv. Representative microscopy images for each set of markers are shown.
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the course of a 5-day infection (data not shown). In contrast to
untreated macrophages, the secA2 mutant and H37Rv grew
equally well in macrophages treated with 10 nM bafilomycin A1
(Fig. 7B). While bafilomycin treatment increased growth of both
H37Rv and the secA2 mutant in macrophages over 5 days (Fig.
7B), the effect of bafilomycin was small and not significant for
H37Rv and significantly greater for the secA2 mutant (Fig. 7C).
To establish the specificity of this rescue, we also tested the effect of
bafilomycin on intracellular growth of the leuD mutant, which is
not localized to acidified phagosomes (Fig. 4A). Bafilomycin A1
treatment of the leuD mutant did not rescue growth to the level
of H37Rv in bafilomycin-treated macrophages (Fig. 7B and C).
Experiments with 5 nM concanamycin A showed the same effect
of rescuing the intracellular-growth defect of the secA2 mutant.
The growth of the secA2 mutant was equivalent to that of H37Rv
in concanamycin A-treated macrophages (Fig. 7D and E). To-
gether, these results indicated the importance of phagosome acid-
ification for inhibiting intracellular growth of the secA2 mutant.
Our data further argue that phagosome maturation can result in
inhibition of M. tuberculosis intracellular replication.
DISCUSSION
The function of the accessory SecA2 export system in promoting
growth in macrophages has remained elusive. Previously, we
tested if the role of the SecA2 system is to protect against the
oxidative or nitrosative stresses produced by macrophages during
infection (33). These past studies showed that even in the absence
of these reactive radical stresses, the secA2 mutant remains at-
tenuated in macrophages. Thus, the SecA2 system must have
other roles in promoting M. tuberculosis growth in macrophages.
In this study, we considered alternate explanations. We tested if
the inhibition of macrophage apoptosis mediated by the SecA2
system is what promotes M. tuberculosis growth in macrophages.
Our results from testing the secA2–-sodA strain do not support
this possibility. While expression of the -sodA construct in the
secA2 mutant suppresses the proapoptotic phenotype, the strain
remained defective for intracellular growth (Fig. 1A). It is worth-
while to note that our results do not rule out other important roles
of the apoptosis phenotype of the M. tuberculosis secA2 mutant,
as reported elsewhere, such as enabling enhanced adaptive im-
mune responses and increased protective immunity in vaccina-
tion studies (25).
In considering other explanations for the function of the SecA2
system in macrophages, we tested the secA2 mutant for the abil-
ity to arrest phagosome maturation. Our results showed the
secA2 mutant to be defective in phagosome maturation arrest, as
the mutant was more readily trafficked to a more mature phago-
some than the parental H37Rv strain. This defect was evident soon
after infection (1 h) and was not exhibited by other mutants with
intracellular-growth defects even at later times postinfection (72
h). Additionally, we showed that treating macrophages with in-
hibitors of the V-ATPase prevented acidification of phagosomes
and rescued the intracellular-growth defect of the secA2 mutant.
From these results, we conclude that the accessory SecA2 export
system has a specific role in blocking phagosome acidification and
FIG 6 MyD88 has no effect on secA2 mutant phagosome trafficking or intracellular growth. (A) Nonactivated BMDM derived from C57BL/6 or MyD88/
mice were infected with H37Rv or the secA2 mutant. At 24 h postinfection, the slides were stained with LysoTracker or antibodies to CD63, Rab7, or V-ATPase
and scored for marker-positive bacterium-containing phagosomes as described in the text. The bars represent mean percentages of bacterium-containing
phagosomes that stain positive for marker; the error bars represent SD of three replicate wells. n.s., not significant. There are no significant differences between
C57BL/6 and MyD88/ macrophages infected with the secA2 mutant. (B) Nonactivated BMDM from C57BL/6 (open symbols) or MyD88/ (closed
symbols) mice were infected with H37Rv or the secA2 mutant, and intracellular replication was monitored as described. The data shown are plotted on a linear
scale and are from a representative experiment out of three; the points are means of three replicate wells, and the error bars represent SD. *, P  0.05 by student’s
t test compared to H37Rv.
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that the intracellular-growth defect of the secA2 mutant is di-
rectly related to its defect in blocking phagosome maturation.
Correlations exist between phagosome maturation and M. tu-
berculosis growth arrest (8, 35, 46, 56), and the ability of M. tuber-
culosis to arrest phagosome maturation is generally assumed to be
critical for pathogenesis and for growth in macrophages. How-
ever, there are a few examples of mutants that are able to grow
even though they reside in more mature phagosomes (8, 36, 46),
which raises the possibility that phagosome maturation arrest is
not essential for M. tuberculosis intracellular growth. Our results
showing that both bafilomycin A1 and concanamycin A rescue the
secA2 mutant intracellular-growth defect are significant in dem-
onstrating the ability of V-ATPase-mediated phagosome acidifi-
cation to control M. tuberculosis growth. This argues that the
avoidance of phagosome acidification by virulent M. tuberculosis
is necessary for intracellular growth. In addition to rescuing
growth of the secA2 mutant, bafilomycin and concanamycin
treatment also modestly increased the replication efficiency of
H37Rv. This effect on H37Rv is most likely due to the inhibitors
further decreasing the percentage of H37Rv associated with acid-
ified phagosomes (Fig. 7). A similar result was reported by Welin
et al. with H37Rv infection of bafilomycin-treated human
monocyte-derived macrophages (68).
How might phagosome acidification control M. tuberculosis
infection? Although low pH can render medium components
toxic to M. tuberculosis, which complicates assessing growth at
acid pH (61), M. tuberculosis replication is reported to be sensitive
to low pH (48). Therefore, it is possible that phagosome acidifica-
tion is directly responsible for the growth inhibition of the secA2
mutant in macrophages. Alternatively, the acidic environment
may activate the pH-sensitive lysosomal hydrolases (52) and
thereby limit replication. A final possibility is that the acidification
of the phagosome drives downstream fusion events that produce
the growth-restricting environment (11, 58).
Because metabolically inactive bacteria are more readily found
in acidified phagosomes (35), it has been suggested that mutants
impaired in any aspect of growth or metabolic activity may be
found in mature phagosomes as a secondary consequence of those
defects, as opposed to a direct effect on phagosome maturation
(47). Because we observed the secA2 mutant in more mature
phagosomes at early times postinfection and because V-ATPase
inhibitors rescued the growth defect, we think it unlikely that gen-
eral growth or metabolic defects account for the secA2 mutant
phenotype. Moreover, we tested the leucine auxotroph (leuD) of
M. tuberculosis as an example of a mutant severely compromised
in metabolic activity. The leuD mutant requires leucine supple-
FIG 7 Growth of the secA2 mutant is inhibited by phagosome acidification. (A) LysoTracker-positive phagosomes in BMDM infected with H37Rv or the
secA2 mutant and treated with bafilomycin A1 or concanamycin A. Shown are the lowest inhibitor concentrations that bring secA2 LysoTracker-positive
phagosomes to H37Rv levels. ND, not determined. (B) Nonactivated BMDM treated with bafilomycin A1 or vehicle control (DMSO) were infected with H37Rv
or the secA2 or leuD mutant, and intracellular replication was monitored as described. Shown is a representative of four independent experiments. The bars
represent the mean fold growth over 5 days of three replicate wells plus SD. *, P  0.05 by Student’s t test. (C) Data from the experiment described in panel B
combined with three independent experiments to show the fold effect of bafilomycin A1 on intracellular growth compared to untreated macrophages. The bars
represent the mean fold effect of bafilomycin A1 in four individual experiments plus the standard errors of the mean (SEM). *, P  0.05 by Student’s t test
compared to H37Rv. (D and E) As in panels B and C, with concanamycin A or DMSO. (D) Shown is a representative of three experiments. (E) The bars represent
the mean fold effect of concanamycin in three experiments plus SEM. *, P  0.05 by Student’s t test compared to H37Rv.
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mentation to grow in liquid medium, and the mutant does not
grow in macrophages, presumably due to a failure to acquire leu-
cine from the intracellular environment (26). Somewhat surpris-
ingly, the leuD mutant behaved like H37Rv and maintained its
ability to avoid phagosome acidification, even at the latest (72-h)
time point. Although the precise level of metabolic activity of the
leuD mutant in macrophages is not known, this result suggests
that general growth or metabolic defects do not necessarily lead to
a breakdown in phagosome maturation arrest.
What is currently known about the process of phagosome mat-
uration arrest by M. tuberculosis suggests it is a complex process
involving several effectors. It seems likely that M. tuberculosis has
multiple effectors targeting a minimum of two parallel pathways
that are critical to phagosome maturation: PI(3)P accumulation/
signaling and Rab7 accumulation/activation (10, 47, 62). The
phagosome maturation defect of the secA2 mutant may be due to
a defect in the secretion of such effectors. Several M. tuberculosis-
secreted proteins (i.e., LpdC, NdkA, PknG, PtpA, and SapM) af-
fect phagosome maturation or pathways thought to be critical for
phagosome maturation (3, 14, 59, 63, 67). This list of possible
effectors is likely incomplete, however, as mutant screens to find
effectors of phagosome maturation suggest the existence of a
much broader set of proteins involved in arresting phagosome
maturation (8, 36, 46, 56). There are also M. tuberculosis surface
lipids (lipoarabinomannan, phosphotidylinositol mannoside,
and tetra-acylated sulfoglycolipid) (8, 21, 64) reported to affect
phagosome maturation. The SecA2 system could be involved in
surface lipid production or localization by exporting lipid synthe-
sis or export machinery.
An alternate way that the SecA2 system could promote phago-
some maturation arrest would be to limit macrophage responses
that drive downstream phagosome maturation events. With this
idea in mind, we considered the possibility that the more robust
MyD88-dependent responses elicited by the secA2 mutant (33)
might be responsible for the altered trafficking of the secA2 mu-
tant. Although our experiments with MyD88/ macrophages re-
vealed this not to be the case, it only excludes altered phagosome
trafficking as a downstream event of MyD88 signaling. Macro-
phages can detect M. tuberculosis through MyD88-independent
intracellular receptors, such as the NLR family of receptors and
the inflammasome, which could also drive phagosome matura-
tion (39).
The microscopy experiments performed in the course of this
work are the first to take advantage of the autofluorescence of
mycobacteria to colocalize intracellular bacilli with phagosomal
markers. Previously, either exogenous fluorescent proteins (GFP
and red fluorescent protein [RFP]) or fluorescent dyes have been
used to track mycobacteria in similar experiments (54, 56). While
GFP fluorescence has the advantage over autofluorescence of be-
ing brighter and longer lasting, it has the disadvantage of requiring
the construction of strains that express exogenous genetic ele-
ments, and there is the potential for GFP expression itself to influ-
ence virulence (42). The use of dyes to surface label the bacilli has
a similar disadvantage in introducing an experimental variable
that could possibly alter the course of infection (54).
The work presented here not only provides a better under-
standing of how SecA2 promotes M. tuberculosis growth in mac-
rophages, it also demonstrates the importance of phagosome mat-
uration arrest for M. tuberculosis. It seems likely that M.
tuberculosis has multiple effectors of phagosome maturation ar-
rest. As is the case in the type IV secretion system of Legionella
pneumophila, this may mean there is substantial effector redun-
dancy (43). The phagosome maturation phenotype of the secA2
mutant indicates there is a single critical effector or multiple ef-
fectors that depend on the SecA2 export pathway. Future studies
will seek to identify such SecA2-dependent effectors of phago-
some maturation arrest.
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